Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis

Genes Chromosomes and Cancer

Volumn 36, Issue 4, 2003, Pages 375-381

  Lestou, Valia S ^a,b   Ludkovski, Olga ^a   Connors, Joseph M ^a,b   Gascoyne, Randy D ^a,b   Lam, Wan L ^b,c   Horsman, Douglas E ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTROMERE; CHROMOSOME BAND; CHROMOSOME BREAKAGE; DICENTRIC CHROMOSOME; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DUPLICATION; GENE LOCUS; GENE TRANSLOCATION; GENETIC ANALYSIS; HUMAN; HUMAN GENOME; MOLECULAR CLONING; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME BANDING; CHROMOSOME BREAKAGE; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TRANSLOCATION, GENETIC;

EID: 0037376396     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10181     Document Type: Article

References (49)

1. Baylin S, Bestor TH. 2002. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1:299-305.
2. Berger R, Busson-Le Coniat M. 1999. Centric and pericentric chromosome rearrangements in hematopoietic malignancies. Leukemia 13:671-678.
3. Boei JJ, Vermeulen S, Natarajan AT. 1998. Dose-response curves for X-ray induced interchanges and interarm intrachanges in human lymphocytes using arm-specific probes for chromosome 1. Mutat Res 404:45-53.
4. Busson-Le Coniat M, Salomon-Nguyen F, Dastugue N, Maarek O, Lafage-Pochitaloff M, Mozziconacci MJ, Baranger L. Brizard F, Radford I, Jeanpierre M, Bernard OA, Berger R. 1999a. Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: rearrangements of DNA satellite II and new recurrent translocations. Leukemia 13:1975-1981.
5. Busson-Le Coniat M, Salomon-Nguyen F, Hillion J, Bernard OA, Berger R. 1999b. MLL-AF1q fusion resulting from t(1;11) in acute leukemia. Leukemia 13:302-306.
6. Byrd JC, Kitada S, Flinn IW, Aron JL, Pearson M, Lucas D, Reed JC. 2002. The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood 99: 1038-1043.
7. Callanan MB, Le Baccon P, Mossuz P, Duley S, Bastard C, Hamoudi R, Dyer MJ, Klobeck G, Rimokh R, Sotto JJ, Leroux D. 2000. The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma. Proc Natl Acad Sci USA 97:309-314.
8. Cobb BS, Morales-Alcelay S, Kleiger G, Brown KE, Fisher AG, Smale ST. 2000. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev 14:2146-2160.
9. Colmenares C, Heilstedt HA, Shaffer LG, Schwartz S, Berk M, Murray JC, Stavnezer E. 2002. Loss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski-/- mice. Nat Genet 30:106-109.
10. Dave BJ, Hess MM, Pickering DL, Zaleski DH, Pfeifer AL, Weisenburger DD, Armitage JO, Sanger WG. Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma. Clin Cancer Res. 1999;5:1401-1409.
11. Dyomin VG, Palanisamy N, Lloyd KO, Dyomina K, Jhanwar SC, Houldsworth J, Chaganti RS. 2000. MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets. Blood 95:2666-2671.
12. Gilles F, Goy A, Remache Y, Shue P, Zelenetz AD. 2000. MUC1 dysregulation as the consequence of a t(1;14)(q21;q32) translocation in an extranodal lymphoma. Blood 95:2930-2936.
13. Hadano S, Nasir J, Nichol K, Rasper DM, Vaillancourt JP, Sherer SW, Beatty BG, Ikeda JE, Nicholson DW, Hayden MR. 1999. Genomic organization of the human caspase-9 gene on chromosome 1p36. 1-p36.3. Mamm Genome 10:757-760.
14. Hatakeyama S, Osawa M, Omine M, Ishikawa F. 1999. JTB: a novel membrane protein gene at 1q21 rearranged in a jumping translocation. Oncogene 18:2085-2090.
15. Hatzivassiliou G, Miller I, Takizawa J, Palanisamy N, Rao PH, Iida S, Tagawa S, Taniwaki M, Russo J, Neri A, Cattoretti G, Clynes R, Mendelsohn C, Chaganti RS, Dalla-Favera R. 2001. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14:277-289.
16. Horsman DE, Connors JM, Pantzar T, Gascoyne RD. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes, Chromosomes & Cancer. 2001;30: 375-382.
17. Inokuchi K, Hamaguchi H, Taniwaki M, Yamaguchi H, Tanosaki S, Dan K. 2001. Establishment of a cell line with AML1-MTG8, TP53, and TP73 abnormalities from acute myelogenous leukemia. Genes Chromosomes Cancer 32:182-187.
18. Jallepalli PV, Lengauer C. 2001. Chromosome segregation and cancer: cutting through the mystery. Nat Rev 1:109-117.
19. Ji W, Hernandez R, Zhang XY, Qu GZ, Frady A, Varela M, Ehrlich M. 1997. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat Res 379:33-41.
20. Johansson B, Mertens F, Mitelman F. 1995. Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 86:3905-3914.
21. Johansson B, Billström R, Broberg K, Fioretos T, Nilsson PG, Ahlgren T, Malm C, Samuelsson BO, Mitelman F. 1999. Cytogenetic polyclonality in hematologic malignancies. Genes Chromosomes Cancer 24:222-229.
22. Knutsen T. 1997. Cytogenetic mechanisms in the pathogenesis and progression of follicular lymphoma. Cancer Surv 30:163-192.
23. Knutsen T. 1998. Cytogenetic changes in the progression of lymphoma. Leuk Lymphoma 31:1-19.
24. Koduru PR, Filippa DA, Richardson ME, Jhanwar SC, Chaganti SR, Koziner B, Clarkson BD, Lieberman PH, Chaganti RS. Cytogenetic and histologic correlations in malignant lymphoma. Blood. 1987;69:97-102.
25. Le Baccon P, Leroux D, Dascalescu C, Duley S, Marais D, Esmenjaud E, Sotto JJ, Callanan M. 2001. Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma. Genes Chromosomes Cancer 32:250-264.
26. Lestou VS, Gascoyne RD, Salski C, Connors JM, Horsman DE. 2002. Uncovering novel inter- and intrachromosomal chromosome 1 aberrations in follicular lymphomas by using an innovative multicolor banding technique. Genes Chromosomes Cancer 34: 201-210.
27. Mitelman F, editor. 1995. An international system for human cytogenetic nomenclature. Basel: S. Karger.
28. Mitelman F. 2000. Recurrent chromosome aberrations in cancer. Mutat Res 462:247-253.
29. Mitelman F, Johansson B, Mertens F, editors. 2002. Mitelman database of chromosome aberrations in cancer. May be accessed at http://cgap.nci.nih.gov/Chromosomes/Mitelman
30. Mochizuki N, Shimizu S, Nagasawa T, Tanaka H, Taniwaki M, Yokota J, Morishita K. 2000. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood 96:3209-3214.
31. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R, Dalla-Favera R. 2001. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412:341-346.
32. Rowley JD. 1999. The role of chromosome translocations in leukemogenesis. Semin Hematol 36:59-72.
33. Salomon-Nguyen F, Della-Valle V, Mauchauffe M, Busson-Le Coniat M, Ghysdael J, Berger R, Bernard OA. 2000. The t(1;12)(q21; p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. Proc Natl Acad Sci USA 97:6757-6762.
34. Sawyer JR, Swanson CM, Wheeler G, Cunniff C. 1995. Chromosome instability in ICF syndrome: formation of micronuclei from multibranched chromosomes 1 demonstrated by fluorescence in situ hybridization. Am J Med Genet 56:203-209.
35. Schutte BC, Carpten JD, Forus A, Gregory SG, Horii A, White PS. 2001. Report and abstracts of the sixth international workshop on human chromosome 1 mapping 2000. Iowa City, Iowa, USA. 30 September-3 October 2000. Cytogenet Cell Genet 92:23-41.
36. Shinagawa T, Nomura T, Colmenares C, Ohira M, Nakagawara A, Ishii S. 2001. Increased susceptibility to tumorigenesis of skideficient heterozygous mice. Oncogene 20:8100-8108.
37. Stiewe T, Putzer BM. 2002. Role of p73 in malignancy: tumor suppressor of oncogene? Cell Death Differ 9:237-245.
38. Sumner AT, Mitchell AR, Ellis PM. 1998. A FISH study of chromosome fusion in the ICF syndrome: involvement of paracentric heterochromatin but not of the centromeres themselves. J Med Genet 35:833-835.
39. Surralles J, Darroudi F, Natarajan AT. 1997. Low level of DNA repair in human chromosome 1 heterochromatin. Genes Chromosomes Cancer 20:173-184.
40. Surralles J, Ramirez MJ, Marcos R, Natarajan AT, Mullenders LH. 2002. Clusters of transcription-coupled repair in the human genome. Proc Natl Acad Sci USA 99:10571-10574.
41. Tuck-Muller CM, Narayan A, Tsien F, Smeets DF, Sawyer J, Fiala ES, Sohn OS, Ehrlich M. 2000. DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet Cell Genet 89:121-128.
42. Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, Koonin EV, Dixit VM. 2000. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 6:961-967.
43. Varga AE, Dobrovic A, Webb GC, Hutchinson R. 2001. Clustering of 1p36 breakpoints distal to 1p36.2 in hematological malignancies. Cancer Genet Cytogenet 125:78-79.
44. Verma RS, Ramesh KH, Mathews T, Kleyman SM, Conte RA. 1996. Centromeric alphoid sequences are breakage prone resulting in pericentromeric inversion heteromorphism of qh region of chromosome 1. Ann Genet 39:205-208.
45. Westman BJ, Mackay JP, Gell D. 2002. Ikaros: a key regulator of haematopoiesis. Int J Biochem Cell Biol 34:1304-1307.
46. Willis TG, Zalcberg IR, Coignet LJ, Wlodarska I, Stul M, Jadayel DM, Bastard C, Treleaven JG, Catovsky D, Silva ML, Dyer MJ. 1998. Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood 91:1873-1881.
47. Xu GL, Bestor TH, Bourc'his D, Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, Viegas-Pequignot E. 1999. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402:187-191.
48. Zhang J, Glatfelter AA, Taetle R, Trent JM. 1999a. Frequent alterations of evolutionarily conserved regions of chromosome 1 in human malignant melanoma. Cancer Genet Cytogenet 111:119-123.
49. Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, Rakestraw KM, Naeve CW, Beckmann G, Weisenburger DD, Sanger WG, Nowotny H, Vesely M, Callet-Bauchu E, Salles G, Dixit VM, Rosenthal A, Schlegelberger B, Morris SW. 1999b. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22; q32). Nat Genet 22:63-68.